位置:首页 > 蛋白库 > TOR_SCHMA
TOR_SCHMA
ID   TOR_SCHMA               Reviewed;         419 AA.
AC   C4QM85; G3LUQ6; Q9U597;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 2.
DT   03-AUG-2022, entry version 50.
DE   RecName: Full=Tetraspanning orphan receptor {ECO:0000303|PubMed:19281639};
DE   AltName: Full=Complement C2 receptor inhibitor tetraspanning {ECO:0000303|PubMed:19281639};
DE   AltName: Full=Complement C2 receptor inhibitor trispanning {ECO:0000303|PubMed:10366712};
DE            Short=SmCRIT {ECO:0000303|PubMed:10366712};
DE   AltName: Full=Trispanning orphan receptor;
DE            Short=Sm-TOR {ECO:0000303|PubMed:10366712};
GN   Name=TOR {ECO:0000303|PubMed:19281639}; ORFNames=Smp_093840;
OS   Schistosoma mansoni (Blood fluke).
OC   Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Platyhelminthes; Trematoda;
OC   Digenea; Strigeidida; Schistosomatoidea; Schistosomatidae; Schistosoma.
OX   NCBI_TaxID=6183;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Larva {ECO:0000269|PubMed:19281639};
RX   PubMed=19281639; DOI=10.1017/s0031182009005757;
RA   Lochmatter C., Schifferli J.A., Martin P.J.;
RT   "Schistosoma mansoni TOR is a tetraspanning orphan receptor on the parasite
RT   surface.";
RL   Parasitology 136:487-498(2009).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF21676.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 139-419, SUBCELLULAR LOCATION, AND POTENTIAL
RP   USE AS A VACCINE.
RX   PubMed=10366712; DOI=10.1016/s0167-4781(99)00051-2;
RA   Inal J.M.;
RT   "Schistosoma TOR (trispanning orphan receptor), a novel, antigenic surface
RT   receptor of the blood-dwelling, Schistosoma parasite.";
RL   Biochim. Biophys. Acta 1445:283-298(1999).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND POTENTIAL USE AS A VACCINE.
RX   PubMed=23121675; DOI=10.1111/j.1365-2249.2012.04667.x;
RA   Lochmatter C., Schneider C.L., Ingram K., Keiser J., Schifferli J.A.;
RT   "Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine
RT   candidate against schistosomiasis.";
RL   Clin. Exp. Immunol. 170:342-357(2012).
CC   -!- FUNCTION: Cell surface receptor that binds to human complement C2a
CC       protein. This results in inhibition of the classical and lectin
CC       pathways of complement activation, probably due to interference with
CC       binding of C2a to C4b and interference with cleavage by C1 or MASP2
CC       such that C3 convertase cannot be formed. This infers resistance to
CC       complement-mediated cell lysis, allowing parasite survival and
CC       infection (By similarity). {ECO:0000250|UniProtKB:Q5J7P3,
CC       ECO:0000250|UniProtKB:Q9BLM6}.
CC   -!- SUBUNIT: Interacts (via N-terminal extracellular domain) with human
CC       C2a. {ECO:0000250|UniProtKB:Q9BLM6}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10366712,
CC       ECO:0000269|PubMed:19281639}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10366712, ECO:0000269|PubMed:19281639}.
CC       Note=Located on the surface tegumental plasma membrane, and tegumental
CC       surface pits of adult schistosomes so in contact with host blood
CC       plasma. {ECO:0000269|PubMed:10366712, ECO:0000269|PubMed:19281639}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in parasitic larvae (cercariae)
CC       and at a lower level in eggs, miracidiae, schistosomulae and adults.
CC       {ECO:0000269|PubMed:19281639}.
CC   -!- PTM: Phosphorylated on tyrosine residues.
CC       {ECO:0000250|UniProtKB:Q9BLM6}.
CC   -!- BIOTECHNOLOGY: Potential vaccine candidate molecule (PubMed:10366712,
CC       PubMed:23121675). Induces an immune response in mice and confers
CC       protection against S.mansoni infection (PubMed:23121675).
CC       {ECO:0000269|PubMed:23121675, ECO:0000305|PubMed:10366712,
CC       ECO:0000305|PubMed:23121675}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JN560697; AEN25587.1; -; mRNA.
DR   EMBL; AF051138; AAF21676.1; -; mRNA.
DR   AlphaFoldDB; C4QM85; -.
DR   TCDB; 2.A.74.1.5; the 4 tms multidrug endosomal transporter (met) family.
DR   EnsemblMetazoa; Smp_093840.1; Smp_093840.1; Smp_093840.
DR   WBParaSite; Smp_093840.1; Smp_093840.1; Smp_093840.
DR   HOGENOM; CLU_1162417_0_0_1; -.
DR   Proteomes; UP000008854; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
PE   1: Evidence at protein level;
KW   Cell membrane; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..419
FT                   /note="Tetraspanning orphan receptor"
FT                   /id="PRO_0000412760"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        29..49
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        50..165
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        166..186
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        187..193
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        194..214
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        215..240
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..261
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        262..419
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          303..328
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CONFLICT        257
FT                   /note="C -> R (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260
FT                   /note="M -> T (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273..274
FT                   /note="RG -> KS (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        299..306
FT                   /note="RNRGNNSI -> PNGSNNPN (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="P -> R (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        319
FT                   /note="P -> L (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        327
FT                   /note="D -> G (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="A -> T (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        398
FT                   /note="L -> V (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="T -> I (in Ref. 2; AAF21676)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   419 AA;  46712 MW;  16D6B81CA4E561D4 CRC64;
     MPRAPALLTN DARHQFTCCL CLHVRTGTII FGITQIIIQL VFISFLFLMT FNPRLIPEDN
     HGNTDPSEDK IRFYVFSTLF RLVPAVSDIH ESLTLPSPGT RNVNGNKLYL GHNVESETNF
     NYDIPPGYKD DVLVDVNNMS PSLVSYTQKN ERGSHEVKIK HFSPYIAVCV TTFSLAFCCF
     MVHGAITKQP THLLPFFFIQ VFDLIICLIH ILGFMSSTSD LRLMIHTKTG PIYIKSTGFT
     FIILSISCMM LAFKAYCLGM VWDCYKYLML NRRGNLLDDW YSDQWGHLST FWSLLRAGRN
     RGNNSIGNSG SPNEPNTRPR PEPITYDPAN DLPKYEDILK IPANAYAPPP YYCSNINGNV
     NTTEASAVTT NTSNSATAAN TTTTTTNTGT TTSVISTLTT TNKDDTQINS APSNAHSSC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024